Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
(4)
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
CEO Appointment
52 week high
|
Strong Performer, Getting Expensive
2970.2000
2.60
(
0.09
%)
NSE
Aug 14, 2026
15:31 PM
New 52W High today
Volume:
789.6K
High vol.+gain this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
07 Aug 2023
CEO Appointment
52 week high
2970.20
0.09%
Healthy recovery in core markets
Buy:
Gland Pharma Ltd.
by
Motilal Oswal
Target: 1560
Target
Motilal Oswal
Gland Pharma has gained
58.98%
in the last 3 Months
More from Gland Pharma Ltd.
Recommended
How India’s top CEOs got paid in FY26
The Baseline |
14 Aug 2026
Five Interesting Stocks Today - August 14, 2026
The Baseline |
14 Aug 2026
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020